Home Cart 0 Sign in  
X

[ CAS No. 41011-01-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 41011-01-2
Chemical Structure| 41011-01-2
Chemical Structure| 41011-01-2
Structure of 41011-01-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 41011-01-2 ]

Related Doc. of [ 41011-01-2 ]

Alternatived Products of [ 41011-01-2 ]

Product Details of [ 41011-01-2 ]

CAS No. :41011-01-2 MDL No. :MFCD00792669
Formula : C8H6BrClO Boiling Point : -
Linear Structure Formula :- InChI Key :KJVRURZDIOVSSQ-UHFFFAOYSA-N
M.W : 233.49 Pubchem ID :38738
Synonyms :

Calculated chemistry of [ 41011-01-2 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.52
TPSA : 17.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.38 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.99
Log Po/w (XLOGP3) : 3.3
Log Po/w (WLOGP) : 2.92
Log Po/w (MLOGP) : 2.82
Log Po/w (SILICOS-IT) : 3.33
Consensus Log Po/w : 2.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.64
Solubility : 0.0537 mg/ml ; 0.00023 mol/l
Class : Soluble
Log S (Ali) : -3.33
Solubility : 0.108 mg/ml ; 0.000463 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.23
Solubility : 0.0139 mg/ml ; 0.0000594 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.62

Safety of [ 41011-01-2 ]

Signal Word:Danger Class:8
Precautionary Statements:P501-P260-P264-P280-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P405 UN#:3261
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 41011-01-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 41011-01-2 ]
  • Downstream synthetic route of [ 41011-01-2 ]

[ 41011-01-2 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 41011-01-2 ]
  • [ 17356-08-0 ]
  • [ 90533-23-6 ]
YieldReaction ConditionsOperation in experiment
93% for 1 h; Reflux Step 2: To a mixture of 2-bromo-1-(3-chlorophenyl)ethan-1-one (0.5 g, 2.1 mmol) and thiourea (0.2 g, 2.3 mmol) in anhydrous EtOH (5 mL) was heated at reflux for 1 h. After that, the solvent was removed in vacuo, and saturated aqueous NaHCO3 was added. The mixture was then extracted with ethyl acetate. The combined organic phases were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure to give 4-(3-chlorophenyl)thiazol-2-amine as a solid (0.4 g, 93percent).
23 g Reflux To a solution of 2-bromo-1-(3-chlorophenyl)ethanone (28 g) in ethanol (300 ml) was added thiourea (10.04 g). The reaction mixture was refluxed overnight. Solvent was removed, and the residue was triturated with diethyl ether to give the title compound (23 g) as a white solid. MS(ES+) m/z 211 (MH+).
Reference: [1] Patent: US2016/257690, 2016, A1, . Location in patent: Paragraph 0727
[2] Medicinal Chemistry Research, 2014, vol. 23, # 1, p. 259 - 268
[3] Patent: WO2012/100734, 2012, A1, . Location in patent: Page/Page column 20
[4] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 5293 - 5302
[5] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 15, p. 3669 - 3674
[6] Patent: WO2017/9650, 2017, A1, . Location in patent: Page/Page column 103
[7] European Journal of Medicinal Chemistry, 2018, vol. 144, p. 179 - 200
[8] Tetrahedron, 2018, vol. 74, # 27, p. 3602 - 3607
  • 2
  • [ 99-02-5 ]
  • [ 41011-01-2 ]
YieldReaction ConditionsOperation in experiment
91% With bromine In n-heptane; water EXAMPLE 5
Under a nitrogen atmosphere, 3'-chloroacetophenone (154.6 g, 1 mol) and anhydrous methanol (310 ml) dried with molecular sieves were charged in a four-necked flask.
Bromine (158.2 g, 0.99 mol) was added dropwise with stirring at a temperature in a range from 30° to 45° C. over one hour, and the mixture was maintained at the same temperature for 10 minutes.
After water (160 g) was added, the solution was cooled to -10° C. to precipitate crystals which were filtered to obtain 250 g of a crude cake.
This crude cake was dissolved in heptane (750 g), and the solution was washed twice with water (200 g), dried over anhydrous magnesium sulfate, filtered, washed and then concentrated to obtain 212.5 g of 2-bromo-3'-chloroacetophenone.
The yield was 91.0percent and no impurity was detected.
91% With bromine In n-heptane; water Reference Example 1
3'-Chloroacetophenone (154.6 g) and anhydrous methanol (dried with a molecular sieves 4A) (310 ml) were charged in a flask, and bromine (158.2 g) was added dropwise under stirring at 30° to 45° C. over one hour.
After continuous stirring at the same temperature for 10 minutes, water (160 g) was added and the mixture was stirred continuously for one hour.
After cooling to -10° C., the crystal deposited was filtered to give 250 g of a solid.
This solid was dissolved in heptane (750 g), and the resulting solution was washed twice with water (200 g), dried over anhydrous magnesium sulfate and filtered.
Then, the filtrate was cooled to -30° C. and the crystal was filtered and dried to give 212.5 g of 2-bromo-3'-chloroacetophenone.
It was analyzed by subjecting to gas chromatography.
As a result, impurities were not observed, yield 91percent.
90% With tetrabutylammomium bromide In acetonitrile at 150℃; for 0.0333333 h; Microwave irradiation; Sealed tube Step 1 [Show Image] 1-(3-chlorophenyl)ethanone 25 (750 mg, 4.85 mmol) was dissolved in acetonitrile (11.5 ml). To the solution was added tetrabutylammonium bromide (2.34 g, 4.85 mmol) and the mixture was in sealed tubes and stirred by a microwave reactor for 2 minutes at 150 °C. The reactant was poured into water and extracted with ethyl acetate. The organic layer was washed with saturated sodium hydrogen carbonate solution, washed with water and dried over anhydrous magnesium sulfate. The solvent was removed under reduced pressure and the residue was purified by silica gel chromatography to give the desired compound 26 (1.02 g, yield 90 percent). 1H-NMR (DMSO-d6) δ: 5.01 (s, 2H), 7.60-7.65 (m, 1H), 7.77-7.80 (m, 1H), 7.96-8.06 (m, 2H).
90% With tetrabutylammomium bromide In acetonitrile at 150℃; for 0.0333333 h; Microwave irradiation; Sealed tubes 1-(3-chlorophenyl)ethanone 25 (750 mg, 4.85 mmol) was dissolved in acetonitrile (11.5 ml). To the solution was added tetrabutylammonium bromide (2.34 g, 4.85 mmol) and the mixture was in sealed tubes and stirred by a microwave reactor for 2 minutes at 150° C. The reactant was poured into water and extracted with ethyl acetate. The organic layer was washed with saturated sodium hydrogen carbonate solution, washed with water and dried over anhydrous magnesium sulfate. The solvent was removed under reduced pressure and the residue was purified by silica gel chromatography to give the desired compound 26 (1.02 g, yield 90percent).1H-NMR (DMSO-d6) δ: 5.01 (s, 2H), 7.60-7.65 (m, 1H), 7.77-7.80 (m, 1H), 7.96-8.06 (m, 2H).
87% With Oxone; ammonium bromide In methanol for 2 h; Reflux General procedure: Oxone (1.352 g, 2.2 mmol) was added to the well stirred solution of substrate (2 mmol) and NH4Br (0.215 g, 2.2 mmol) in methanol (10 ml) and the reaction mixture was allowed to stir at room temperature (or reflux temperature). After completion of the reaction, as monitored by TLC, the reaction mixture was quenched with aqueous sodium thiosulfate, and extracted with ethyl acetate (3.x.25 ml). Finally, the combined organic layer was washed with water, dried over anhydrous sodium sulfate, filtered and removal of solvent in vacuo yielded a crude residue, which was further purified by column chromatography over silica gel (finer than 200 mesh) to afford pure products. All the products were identified on the basis of 1H NMR and mass spectral data.
82.2% With bromine In dichloromethane at 20 - 25℃; for 0.5 h; Preparation No.M.l: 2-Bromo-l-(3-chIorophenyl)-ethanone; EPO <DP n="117"/>To a stirred solution of 3-chloroacetophenone (18.2 g, 0.118 mol) in DCM (150 mL, 2.3 mol), at about 20-25 0C was added drop-wise a solution of bromine (6.00 mL, 0.116 mol) in DCM (20 mL) over about 15 min. After the addition was complete the pale yellow solution was stirred at ambient temperature for about 15 min. Ice-cold water (100 mL) was added to the reaction solution and stirred for about 5 min. The organic layer was separated and washed with ice-cold water (2 x 150 mL). The organic layer was dried over MgSO4, filtered, and the solvent removed in vacuo to yield a pale yellow oil (31.0Ig). The oil residue was stirred with petroleum ether [bp 30-60 0C] (5OmL) at about 40 0C for about 5 min and almost all the oil had dissolved. A magnetic stirrer bar was added to the mixture and rapidly stirred whilst the internal temperature was reduced to about -10 to -5 0C. Held at about -5 0C for about 5 min before the off-white solid was collected. The crystalline solid was washed with ice-cold petroleum ether [bp 30-60 0C] (2 x 40 mL) and dried under reduced pressure to yield an off-white powdery solid (23.8 g, 82.2percent): 1H NMR (400 MHz5CDCl3) δ 7.96 (IH), δ 7.86 (IH), δ 7.59 (IH), δ 7.45 (IH), δ 4.42 (2H); TLC (EtOAc/heptane 1:1) Rf 0.59.
72.8% With copper(I) bromide In ethyl acetate at 80℃; A) 3-Chloroacetophenone (0.2 g, 1.294 mmol)And copper bromide (0.347 g, 1.552 mmol)Were successively dissolved in ethyl acetate (30 mL)The mixture was stirred overnight at 80 ° C,The reaction solution was cooled to room temperature,Further, 30 mL of ethyl acetate was added,The reaction mixture was washed with 100 mL of water,100 mL of saturated sodium chloride solution,The ethyl acetate layer was separated,Dried over anhydrous sodium sulfate,The organic solvent was distilled off under reduced pressure,The residue was purified by flash silica gel column chromatography,Eluting with petroleum ether / ethyl acetate (V / V = 10: 1)To obtain 220 mg of 2-bromo-1- (3-chlorophenyl) ethanone,As a white solid,Yield 72.8percent
18 g With copper(ll) bromide In chloroform; ethyl acetateReflux To a solution of 1-(3-chlorophenyl)ethanone (15 g) in chloroform (100 ml) and ethyl acetate (100 ml) was added copper(II) bromide (21.67 g), and the reaction mixture was refluxed overnight. The reaction mixture was concentrated to give the desired product (18 g) as a brown oil. MS(ES+) m/z 219 (MH+).

Reference: [1] Tetrahedron, 1992, vol. 48, # 1, p. 67 - 78
[2] Journal of Medicinal Chemistry, 1992, vol. 35, # 16, p. 3045 - 3049
[3] Patent: US5717116, 1998, A,
[4] Patent: US5831132, 1998, A,
[5] Patent: EP2280000, 2011, A1, . Location in patent: Page/Page column 40-41
[6] Patent: US2011/28468, 2011, A1, . Location in patent: Page/Page column 26
[7] Tetrahedron Letters, 2012, vol. 53, # 2, p. 191 - 195
[8] Synthetic Communications, 2013, vol. 43, # 19, p. 2603 - 2614
[9] Patent: WO2007/28051, 2007, A2, . Location in patent: Page/Page column 115-116
[10] Journal of Organic Chemistry, 2013, vol. 78, # 14, p. 7312 - 7317
[11] Journal of Medicinal Chemistry, 2013, vol. 56, # 10, p. 3833 - 3851
[12] Patent: CN103833671, 2016, B, . Location in patent: Paragraph 0074; 0075; 0076; 0077
[13] RSC Advances, 2014, vol. 4, # 107, p. 62308 - 62320
[14] Tetrahedron Letters, 1999, vol. 40, # 24, p. 4551 - 4554
[15] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1986, vol. 25, p. 228 - 229
[16] Journal of the Indian Chemical Society, 2002, vol. 79, # 5, p. 469 - 471
[17] Journal of Medicinal Chemistry, 1971, vol. 14, # 10, p. 977 - 982
[18] Pharmazie, 1988, vol. 43, # 7, p. 470 - 472
[19] Journal of Pharmaceutical Sciences, 1982, vol. 71, # 5, p. 556 - 561
[20] Chemical & Pharmaceutical Bulletin, 1995, vol. 43, # 9, p. 1497 - 1504
[21] Journal of agricultural and food chemistry, 2002, vol. 50, # 12, p. 3486 - 3490
[22] Synthesis, 2004, # 11, p. 1750 - 1754
[23] Synthetic Communications, 2007, vol. 37, # 2, p. 199 - 207
[24] Bioscience, Biotechnology and Biochemistry, 2005, vol. 69, # 1, p. 79 - 86
[25] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 5, p. 1291 - 1295
[26] Patent: WO2008/64136, 2008, A2, . Location in patent: Page/Page column 43
[27] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 4, p. 1432 - 1435
[28] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 1, p. 182 - 185
[29] Patent: WO2012/27965, 2012, A1, . Location in patent: Page/Page column 20
[30] Patent: WO2012/100734, 2012, A1, . Location in patent: Page/Page column 19
[31] Synlett, 2012, vol. 23, # 12, p. 1797 - 1800
[32] European Journal of Medicinal Chemistry, 2012, vol. 54, p. 403 - 412
[33] European Journal of Medicinal Chemistry, 2012, vol. 57, p. 407 - 416
[34] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 1, p. 153 - 157
[35] Journal of Medicinal Chemistry, 2013, vol. 56, # 1, p. 84 - 96
[36] Journal of Organic Chemistry, 2013, vol. 78, # 12, p. 6276 - 6280
[37] Angewandte Chemie - International Edition, 2013, vol. 52, # 44, p. 11632 - 11636[38] Angew. Chem., 2013, vol. 125, # 44, p. 11846 - 11850,5
[39] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 24, p. 6764 - 6768
[40] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 2, p. 692 - 702
[41] Medicinal Chemistry Research, 2014, vol. 23, # 1, p. 259 - 268
[42] Patent: WO2014/70978, 2014, A1, . Location in patent: Page/Page column 34; 35
[43] Chemical Biology and Drug Design, 2015, vol. 86, # 4, p. 849 - 856
[44] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 17, p. 5293 - 5302
[45] MedChemComm, 2016, vol. 7, # 7, p. 1441 - 1448
[46] Phosphorus, Sulfur and Silicon and the Related Elements, 2016, vol. 191, # 8, p. 1166 - 1173
[47] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 15, p. 3669 - 3674
[48] Organic and Biomolecular Chemistry, 2016, vol. 14, # 34, p. 8026 - 8029
[49] Patent: CN105315279, 2016, A, . Location in patent: Paragraph 0156
[50] Patent: CN105669586, 2016, A, . Location in patent: Paragraph 0074
[51] Patent: WO2017/9651, 2017, A1, . Location in patent: Page/Page column 40; 41
[52] Journal of Medicinal Chemistry, 2017, vol. 60, # 4, p. 1591 - 1597
[53] Organic Letters, 2017, vol. 19, # 8, p. 1994 - 1997
[54] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 16, p. 3726 - 3732
[55] Organic and Biomolecular Chemistry, 2017, vol. 15, # 38, p. 8134 - 8139
[56] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 8, p. 1986 - 1995
[57] Tetrahedron Letters, 2018, vol. 59, # 33, p. 3214 - 3219
  • 3
  • [ 99-02-5 ]
  • [ 25847-29-4 ]
  • [ 41011-01-2 ]
YieldReaction ConditionsOperation in experiment
80% With N-Bromosuccinimide; silica gel In methanol for 0.366667 h; Reflux General procedure: The α-bromination reaction was carried out using acetophenone (1200 mg, 10 mmol), N-bromosuccinimide (2136 mg, 12 mmol), 10percent (w/w) silica gel (120mg) in 10 mL of methanol at reflux conditions until the disappearance of the substrate. (Note: 2136mg of N-bromosuccinimide was added portion wise i.e. 356 mg for each time in six portions). The progress of the reaction was monitored by TLC. The reaction mass was filtered after the completion of the reaction as per TLC and the catalyst was collected for reuse. The filtrate was concentrated under vacuum. Double distilled water was added to the reaction mixture and quenched with aqueous sodium thiosulfate and the product extracted with dichloromethane (Caution: Severe burning sensation of eyes was observed during the work-up process). The layers were separated and the organic layer was collected and washed thrice with distilled water (3×50mL). The collected organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The obtained crude product was purified by column chromatography over silica gel (60–120 mesh) using n-hexane–EtOAc (99:1 ratio). With the aim of studying the recycling of the catalyst, the isolated catalyst was washed with ethyl acetate (5mL) after its filtration from the reaction medium, collected and dried in vacuum at 70°C to a constant weight. Subsequently it was reused for the α-bromination of acetophenone and achieved 95percent, 86percent and 83percent yields of product (2a) for first, second and third reuse of catalyst respectively. All products gave spectroscopic data in agreement with the literature [15,21,27–30]. The method is also very practical for scale up in process development. We attempted large scale (100 gram scale) synthesis of 2-bromo-1-phenylethanone 2a and obtained fruitful results with isolated yields ranging from 93percent to 96percent.
Reference: [1] Chinese Chemical Letters, 2014, vol. 25, # 1, p. 179 - 182
  • 4
  • [ 1616490-77-7 ]
  • [ 41011-01-2 ]
Reference: [1] Chemical Communications, 2017, vol. 53, # 49, p. 6565 - 6568
  • 5
  • [ 2039-85-2 ]
  • [ 41011-01-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2017, vol. 15, # 46, p. 9889 - 9894
[2] Tetrahedron, 2018, vol. 74, # 27, p. 3602 - 3607
  • 6
  • [ 766-83-6 ]
  • [ 41011-01-2 ]
Reference: [1] European Journal of Organic Chemistry, 2017, vol. 2017, # 4, p. 781 - 785
  • 7
  • [ 99-02-5 ]
  • [ 41011-01-2 ]
Reference: [1] Patent: US5859035, 1999, A,
  • 8
  • [ 104615-49-8 ]
  • [ 220269-85-2 ]
  • [ 41011-01-2 ]
Reference: [1] Patent: US6300363, 2001, B1,
[2] Patent: US6277878, 2001, B1,
  • 9
  • [ 1128-76-3 ]
  • [ 74-95-3 ]
  • [ 41011-01-2 ]
Reference: [1] Journal of Organic Chemistry, 1985, vol. 50, # 25, p. 5140 - 5142
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 41011-01-2 ]

Aryls

Chemical Structure| 53631-13-3

[ 53631-13-3 ]

2-Bromo-1-(3,5-dichlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 2632-10-2

[ 2632-10-2 ]

2-Bromo-1-(3,4-dichlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 536-38-9

[ 536-38-9 ]

2-Bromo-4′-chloroacetophenone

Similarity: 0.98

Chemical Structure| 1011-26-3

[ 1011-26-3 ]

2-Bromo-1-(4-chlorophenyl)butan-1-one

Similarity: 0.90

Chemical Structure| 2631-72-3

[ 2631-72-3 ]

2-Bromo-1-(2,4-dichlorophenyl)ethanone

Similarity: 0.87

Bromides

Chemical Structure| 53631-13-3

[ 53631-13-3 ]

2-Bromo-1-(3,5-dichlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 2632-10-2

[ 2632-10-2 ]

2-Bromo-1-(3,4-dichlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 536-38-9

[ 536-38-9 ]

2-Bromo-4′-chloroacetophenone

Similarity: 0.98

Chemical Structure| 1011-26-3

[ 1011-26-3 ]

2-Bromo-1-(4-chlorophenyl)butan-1-one

Similarity: 0.90

Chemical Structure| 2631-72-3

[ 2631-72-3 ]

2-Bromo-1-(2,4-dichlorophenyl)ethanone

Similarity: 0.87

Chlorides

Chemical Structure| 53631-13-3

[ 53631-13-3 ]

2-Bromo-1-(3,5-dichlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 2632-10-2

[ 2632-10-2 ]

2-Bromo-1-(3,4-dichlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 536-38-9

[ 536-38-9 ]

2-Bromo-4′-chloroacetophenone

Similarity: 0.98

Chemical Structure| 1011-26-3

[ 1011-26-3 ]

2-Bromo-1-(4-chlorophenyl)butan-1-one

Similarity: 0.90

Chemical Structure| 2631-72-3

[ 2631-72-3 ]

2-Bromo-1-(2,4-dichlorophenyl)ethanone

Similarity: 0.87

Ketones

Chemical Structure| 53631-13-3

[ 53631-13-3 ]

2-Bromo-1-(3,5-dichlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 2632-10-2

[ 2632-10-2 ]

2-Bromo-1-(3,4-dichlorophenyl)ethanone

Similarity: 0.98

Chemical Structure| 536-38-9

[ 536-38-9 ]

2-Bromo-4′-chloroacetophenone

Similarity: 0.98

Chemical Structure| 1011-26-3

[ 1011-26-3 ]

2-Bromo-1-(4-chlorophenyl)butan-1-one

Similarity: 0.90

Chemical Structure| 2631-72-3

[ 2631-72-3 ]

2-Bromo-1-(2,4-dichlorophenyl)ethanone

Similarity: 0.87